Delving Into the Recent Advancements of Spinal Cord Injury Treatment: A Review of Recent Progress

Joseph A Flack, Krishna Deo Sharma, Jennifer Yanhua Xie

Delving Into the Recent Advancements of Spinal Cord Injury Treatment: A Review of Recent Progress

2022

Neural Regeneration Research (Wolters Kluwer Health)

brain-computer interface
epidural stimulation
exosomes
neuroprotection
neuroregeneration
scaffolds
spinal cord injury management
stem cells
transplantation

English

Spinal cord injury (SCI) research is a very complex field lending to why reviews of SCI literatures can be beneficial to current and future researchers. This review focuses on recent articles regarding potential modalities for the treatment and management of SCI. The modalities were broken down into four categories: neuroprotection-pharmacologic, neuroprotection-non-pharmacologic, neuroregeneration-pharmacologic, neuroregeneration-non-pharmacologic. Peer-reviewed articles were found using PubMed with search terms: “spinal cord injury”, “spinal cord injury neuroregeneration”, “olfactory ensheathing cells spinal cord injury”, “rho-rock inhibitors spinal cord injury”, “neural stem cell”, “scaffold”, “neural stem cell transplantation”, “exosomes and SCI”, “epidural stimulation SCI”, “brain-computer interfaces and SCI”. Most recent articles spanning two years were chosen for their relevance to the categories of SCI management and treatment. There has been a plethora of pre-clinical studies completed with their results being difficult to replicate in clinical studies. Therefore, scientists should focus on understanding and applying the results of previous research to develop more efficacious preclinical studies and clinical trials.

Neural Regeneration Research, vol. 17, no. 2, Jan. 2022, pp. 283–91

Copyright : © Neural Regeneration Research
This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

PDF